Untitled Document
European Gynecologic Oncology Congress


Home  |  Overview  |  Agenda  |  Venue & Location  |  Registration  |  Cancellation  |  Contact
 
 

Agenda


Chairs:

    Andreas du Bois, MD, PhD

    Dr. Horst-Schmidt-Kliniken

    Wiesbaden, Germany

    
    Eric Pujade-Lauraine, MD, PhD

    Centre Hospitalier Universitaire Hotel-Dieu

    Paris, France


Faculty:

    Xavier Bosch, MD, PhD
    Institut Catala d'Oncologia
    Barcelona, Spain
   
    Andrew Clamp, MD, PhD
    Cancer Research UK, Christie Hospital, 
    United Kingdom
    
    Phillip Harter, MD
    Dr. Horst Schmidt Klinik, 
    Wiesbaden, Germany
    
    Stanley B. Kaye, MD
    The Royal Marsden Hospital & Institute of Cancer Research
    Sutton, United Kingdom

    
    Fabrice Lécuru, MD, PhD
    Hôpital Européen Georges Pompidou
    Paris, France


    Mansoor R. Mirza, MD
    Rigshopitalet, Copenhagen University Hospital
    Copenhagen, Denmark
    
    Jacobus Pfisterer, MD, PhD
    Hospital Solingen
    Germany


    Sandro Pignata, MD, PhD
    Istituto Nazionale Tumori
    Napoli, Italy
    
    Gordon J.S. Rustin, MD, FRCP
    The Clocktower Mount Vernon Hospital
    Northwood, United Kingdom


    Ignace Vergote, MD, PhD
    University Hospital Gasthuisberg
    Leuven, Belgium

    


Friday, 12 February 2010
11.30    Registration and lunch
13.00   Welcome and introduction
     
Session I:   Cervical Cancer
13.05   Interactive oncology challenge
13.10    

Strategies for cervical cancer prevention

13.40  

New concepts in the staging of cervical cancer

14.10   Interactive clinical case: Locally advanced stage cervical carcinoma: Evaluating the options
14.40   Break 
     
Session II:   Ovarian Cancer I: Surgery and First-Line Therapy
15.10   Interactive oncology challenge
15.15 State of the art surgical strategies in ovarian cancer: How to do it?
15.45

State of the art surgical strategies in ovarian cancer: When to do it?

16.15   Interactive clinical case: First-line systemic therapies for ovarian cancer
16.45 Definition and characterization of low-grade and high-grade ovarian serous carcinomas
17.15 Adjourn
17.30 Reception
     
Saturday, 13 February 2010
07.30   Breakfast
09.00   Welcome and introduction
     
Session III:   Endometrial Cancer
09.05   Interactive oncology challenge
09.10   State of the art surgical and radiotherapy strategies in endometrial carcinoma
09.40  

Interactive clinical case: Systemic therapy for endometrial cancer: A new standard?

10.10 Break
     
Session IV:   Ovarian Cancer II: A Case-Based Approach to Recurrence
10.40  

Interactive oncology challenge

10.45  

Interactive clinical case: non surgical Management of platinum sensitive ovarian cancer

11.15   Interactive clinical case: Considerations for the management of a partially platinum sensitive relapse (6-12 months)
11.45   Interactive clinical case: Management of platinum resistant/refractory ovarian cancer
12.15   Lunch
13.30

Keynote Lecture:

Changing standards of care: The role of CA125 in the management of Ovarian Cancer

     
Session V:   Ovarian Cancer III: Novel Therapies
14.15   Interactive oncology challenge
14.20   Emerging options in antiangiogenic targeted therapy for ovarian cancer
14.50   Targeted therapy for ovarian cancer: Beyond angiogenesis
15.20   Oncology challenge results
15.25 Concluding remarks
15.30   Adjourn
     
     

Print Materials